In Vitro Prevention and Reversal of Lipopolysaccharide Desensitization by IFN-γ, IL-12, and Granulocyte-Macrophage Colony-Stimulating Factor

Journal of Immunology

Volumn 158, Issue 6, 1997, Pages 2911-2918

  Randow, Felix ^a,c   Döcke, Wolf Dietrich ^a   Bundschuh, Daniela S ^b   Hartung, Thomas ^b   Wendel, Albrecht ^b   Volk, Hans Dieter ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b UNIVERSITY OF KONSTANZ   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 12; LIPOPOLYSACCHARIDE;

ARTICLE; BIOSYNTHESIS; DESENSITIZATION; DRUG EFFECT; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; METABOLISM; MONOCYTE; MONONUCLEAR CELL;

DESENSITIZATION, IMMUNOLOGIC; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; IMMUNE TOLERANCE; INTERFERON TYPE II; INTERLEUKIN-12; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; MONOCYTES;

EID: 0031569105     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Beeson, P. B. 1947. Tolerance to bacterial pyrogen. J. Exp. Med. 86:29.
2. Granowitz, E. V., R. Porat, J. W. Mier, S. F. Orencole, G. Kaplanski, E. A. Lynch, K. Ye, E. Vannier, S. M. Wolff, and C. A. Dinarello. 1993. Intravenous endotoxin suppresses the cytokine response of peripheral blood mononuclear cells of healthy humans. J. Immunol. 151:1637.
3. Mengozzi, M., and P. Ghezzi. 1993. Cytokine down-regulation in endotoxin tolerance. Eur. Cytokine Netw. 4:89.
4. Sanchez-Cantu, L., H. N. Rode, and N. V. Christou. 1989. Endotoxin tolerance is associated with reduced secretion of tumor necrosis factor. Arch. Surg. 124: 1432.
5. Erroi, A., G. Fantuzzi, M. Mengozzi, M. Sironi, S. F. Orencole, B. D. Clark, C. A. Dinarello, A. Isetta, P. Gnocchi, M. Giovarelli. 1993. Differential regulation of cytokine production in lipopolysaccharide tolerance in mice. Infect. Immun. 61: 4356.
6. Randow, F., U. Syrbe, C. Meisel, D. Krausch, H. Zuckermann, C. Platzer, and H.-D. Volk. 1995. Mechanism of endotoxin desensitization: involvement of interleukin 10 and transforming growth factor beta. J. Exp. Med. 181:1887.
7. Knopf, H. P., F. Otto, R. Engelhardt, M. A. Freudenberg, C. Galanos, F. Herrmann, and R. R. Schumann. 1994. Discordant adaptation of human peritoneal macrophages to stimulation by lipopolysaccharide and the synthetic lipid A analogue SDZ MRL 953. J. Immunol. 153:287.
8. Henricson, B. E., C. L. Manthey, P. Y. Perera, T. A. Hamilton, and S. N. Vogel. 1993. Dissociation of lipopolysaccharide (LPS)-inducible gene expression in murine macrophages pretreated with smooth LPS versus monophosphoryl lipid A. Infect. Immun. 61:2325.
9. Tiegs, G., J. Barsig, B. Matiba, S. Uhlig, and A. Wendel. 1994. Potentiation by granulocyte macrophage colony-stimulating factor of lipopolysaccharide toxicity in mice. J. Clin. Invest. 93:2616.
10. Chomarat, P., M. C. Rissoan, J. Banchereau, and P. Miossec. 1993. Interferon gamma inhibits interleukin 10 production by monocytes. J. Exp. Med. 177:523.
11. Chehimi, J., and G. Trinchieri. 1994. Interleukin-12: a bridge between innate resistance and adaptive immunity with a role in infection and acquired immunodeficiency. J. Clin. Immunol. 14:149.
12. Matic, M., and S. R. Simon. 1992. Effects of gamma interferon on release of tumor necrosis factor alpha from lipopolysaccharide-tolerant human monocyte-derived macrophages. Infect. Immun. 60:3756.
13. Mengozzi, M., M. Sironi, M. Gadina, and P. Ghezzi. 1991. Reversal of defective IL-6 production in lipopolysaccharide-tolerant mice by phorbol myristate acetate. J. Immunol. 147:899.
14. Haas, J. G., N. Meyer, G. Riethmuller, and H. W. Ziegler-Heitbrock. 1990. Inhibition of lipopolysaccharide-induced in vitro desensitization by interferon-gamma. Eur. J. Immunol. 20:1181.
15. Cannistra, S. A., E. Vellenga, P. Groshek, A. Rambaldi, and J. D. Griffin. 1988. Human granulocyte-monocyte colony-stimulating factor and interleukin 3 stimulate monocyte cytotoxicity through a tumor necrosis factor-dependent mechanism. Blood 71:672.
16. Wing, E. J., D. M. Magee, T. L. Whiteside, S. S. Kaplan, and R. K. Shadduck. 1989. Recombinant human granulocyte/macrophage colony-stimulating factor enhances monocyte cytotoxicity and secretion of tumor necrosis factor alpha and interferon in cancer patients. Blood 73:643.
17. Brunda, M. J. 1994. Interleukin-12. J. Leukocyte Biol. 55:280.
18. Hunter, C. A., C. S. Subauste, V. H. Van-Cleave, and J. S. Remington. 1994. Production of gamma interferon by natural killer cells from Tomplasma gondii-infected SCID mice: regulation by interleukin-10, interleukin-12, and tumor necrosis factor alpha. Infect. Immun. 62:2818.
19. Hunter, C. A., L. Bermudez, H. Beernink, W. Waegell, and J. S. Remington 1995. Transforming growth factor-beta inhibits interleukin-12-induced production of interferon-gamma by natural killer cells: a role for transforming growth factor-beta in the regulation of T cell-independent resistance to Toxoplasma gundii. Eur. J. Immunol. 25:994.
20. Scharton-Kersten, T., L. C. Afonso, M. Wysocka, G. Trinchieri, and P. Scott. 1995. IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis. J. Immunol. 154:5320.
21. Tripp, C. S., S. F. Wolf, and E. R. Unanue. 1993. Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist. Proc. Natl. Acad. Sci. USA 90:3725.
22. D'Andrea, A., M. Aste-Amezaga, N. M. Valiante, X. Ma, M. Kubin, and G. Trinchieri. 1993. Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J. Exp. Med. 178:1041.
23. Lenz, A., R. Sabat, F. Randow, H.-D. Volk, and W. D. Döcke. 1996. Differential effects of sepsis mediators on in vitro type 1/type 2 cytokine production: prevention and reversal of type 2 switch by anti-IL-10 and IL-12, respectively. Immunobiology 196:71.
24. Bundschuh, D. S., J. Barsig, T. Hartung, F. Randow, W.-D. Döcke, H.-D. Volk, and A. Wendel. 1997. Granulocyte-macrophage colony-stimulating factor and IFN-γ restore the systemic TNF-a response to endotoxin in lipopolysaccharide-desensitized mice. J. Immunol. This issue.
25. Barsig, J., S. Küsters, K. Vogt, H.-D. Volk, G. Tiegs, and A. Wendel. 1995. Lipopolysaccharide-induced interleukin-10 in mice: role of endogenous tumor necrosis factor-α. Eur. J. Immunol. 25:2888.
26. Glauser, M. P., G. Zanetti, J. D. Baumgartner, and J. Cohen. 1991. Septic shock: pathogenesis. Lancet 338:732.
27. Giri, J. G., J. Wells, S. K. Dower, C. E. McCall, R. N. Guzman, J. Slack, T. A. Bird, K. Shanebeck, K. H. Grabstein, J. E. Sims, and M. R. Alderson. 1994. Elevated levels of shed type II IL-1 receptor in sepsis: potential role for type II receptor in regulation of IL-1 responses. J. Immunol. 153:5802.
28. McCall, C. E., L. M. Grosso-Wilmoth, K. LaRue, R. N. Guzman, and S. L. Cousart. 1993. Tolerance to endotoxin-induced expression of the interleukin-1 beta gene in blood neutrophils of humans with the sepsis syndrome. J. Clin. Invest. 91:853.
29. Munoz C., J. Carlet, C. Fitting, B. Misset, I. P. Bleriot, and J. M. Cavaillon. 1991. Dysregulation of in vitro cytokine production by monocytes during sepsis. J. Clin. Invest. 88:1747.
30. Volk, H. D., M. Thieme, U. Ruppe, S. Heym, W.-D. Döcke, D. Manger, S. Zuckermann, A. Golosubow, B. Nieter, H. Klug, and R. von Baehr. 1993. Alterations in function and phenotype of monocytes from patients with septic disease: predictive value and new therapeutic strategies. In Host Defense Dysfunction in Trauma, Shock and Sepsis. E. Faist and J. L. Meakins, eds. Springer-Verlag, Berlin, pp. 246-271.
31. Döcke, W. D., U. Syrbe, A. Meinecke, C. Platzer, A. Makki, K. Asadullah, C. Klug, H. Zuckermann, P. Reinke, H. Brunner, R. von Baehr, and H. D. Volk. 1994. Improvement of monocytic function: a new therapeutic approach? In Sepsis-Current Perspectives in Pathophysiology and Therapy. K. Reinhart, K. Eyrich, and C. Sprung, eds. Springer-Verlag, Berlin, pp. 473-500.